About BioNet Pharma
BioNet Pharma GmbH emerged from former Scil Technology GmbH, originated from the Scil Group in 2003. The Scil Group was founded by the late Dr. Stefan Engelhorn in 1999 who was a member of one of the families who owned Boehringer Mannheim, which was acquired by Hoffman La Roche in 1998.
The company is located in Munich.
Several projects have passed preclinical proof of concept and a further two development programs have successfully passed clinical phase II at Scil Technology. License deals have been concluded with leading pharma companies for development programs for different indications.
Scil Technology distinguishes through its unique expertise in drug development covering the whole value chain from target validation up to clinical phase III.